Changes in circulating cytokine levels in midlife women with psychological symptoms with selective serotonin reuptake inhibitor and Japanese traditional medicine

Maturitas

Volumn 62, Issue 2, 2009, Pages 146-152

  Yasui, Toshiyuki ^a   Yamada, Masayo ^a   Uemura, Hirokazu ^a   Ueno, Shu ichi ^b   Numata, Shusuke ^c   Ohmori, Tetsuro ^c   Tsuchiya, Naoko ^d   Noguchi, Masamichi ^d   Yuzurihara, Mitsutoshi ^d   Kase, Yoshio ^d   Irahara, Minoru ^a  

^a Human Development and Health Science   (Japan)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

^d Tsumura Central Research Institute   (Japan)

Author keywords

Interleukin 6; Japanese traditional medicine; Midlife women; Psychological symptoms; SSRI

Indexed keywords

ANGELICA ROOT EXTRACT; ANTIDEPRESSANT AGENT; ATRACTYLODIS LANCEAE EXTRACT; BUPLEURUM ROOT EXTRACT; CYTOKINE; ESTRADIOL; FOLLITROPIN; GAMMA INTERFERON; GARDENIA EXTRACT; GINGER EXTRACT; GLYCYRRHIZA EXTRACT; HOELEN EXTRACT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; KAMISHOYOSAN; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MENTHA EXTRACT; MONOCYTE CHEMOTACTIC PROTEIN 1; PAEONIA EXTRACT; PAEONIA SUFFRUTICOSA EXTRACT; PAROXETINE; PLANT EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ANGELICA; ANXIETY DISORDER; ARTICLE; ATRACTYLODIS LANCEAE; BARK; BUPLEURUM; CLIMACTERIUM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFECT; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG SYNTHESIS; DRUG WITHDRAWAL; ESTRADIOL BLOOD LEVEL; EVOKED SOMATOSENSORY RESPONSE; FEMALE; FOLLITROPIN BLOOD LEVEL; GARDENIA; GASTROINTESTINAL SYMPTOM; GINGER; GLYCYRRHIZA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOELEN; HOT FLUSH; HUMAN; INVOLUTIONAL DEPRESSION; JAPANESE; MEDICINAL PLANT; MENOPAUSAL SYNDROME; MENTHA; NAUSEA; PAEONIA; PAEONIA SUFFRUTICOSA; PLANT ROOT; POSTMENOPAUSE; PREMENOPAUSE; PROTEIN BLOOD LEVEL; RATING SCALE; RHIZOME; TRADITIONAL MEDICINE; TREATMENT DURATION; TREATMENT RESPONSE; VASOMOTOR REFLEX;

ADMINISTRATION, ORAL; ANGIOSPERMS; CLIMACTERIC; CYTOKINES; DEPRESSION; DRUGS, CHINESE HERBAL; HOT FLASHES; HUMANS; MEDICINE, EAST ASIAN TRADITIONAL; MIDDLE AGED; PAROXETINE; PHYTOTHERAPY; PLANT EXTRACTS; SEROTONIN UPTAKE INHIBITORS;

EID: 61349183097     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2008.12.007     Document Type: Article

References (37)

1. Edwards J.G., and Anderson I. Systemic review and guide to selection of selective serotonin reuptake inhibitors. Drugs 57 (1999) 507-533
2. Ushiroyama T., Ikeda A., and Ueki M. Kami-Shoyo-San, a herbal medicine, reduces plasma interleukin-6 (IL-6) and soluble IL-6 receptor concentrations in depressive climacteric women. J Trad Med 20 (2003) 150-155
3. Ushiroyama T., Ikeda A., Sakuma K., and Ueki M. Changes in serum tumor necrosis factor (TNF-α) with Kami-Shoyo-San administration in depressed climacteric patients. Am J Chin Med 32 (2004) 621-629
4. Yamada K., and Kanba S. Effectiveness of kamishoyosan for premenstrual dysphoric disorder: open-labeled pilot study. Psychiatr Clin Neurosci 61 (2007) 323-325
5. Schiepers O.J., Wichers M.C., and Maes M. Cytokines and major depression. Prog Neurophychopharmacol Biol Psychiatry 29 (2005) 201-217
6. Maes M., Meltzer H.Y., Bosmans E., et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disorders 34 (1995) 301-309
7. Alesci S., Martinez P.E., Kelkar S., et al. Major depression is associated with significant diurnal elevation in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab 90 (2005) 2522-2530
8. Seidel A., Arolt V., Hunstiger M., Rink L., Behnisch A., and Kirchner H. Cytokine production and serum proteins in depression. Scand J Immunol 41 (1995) 534-538
9. Ushiroyama T., Ikeda A., and Ueki M. Elevated plasma interleukin-6 (IL-6) and soluble IL-6 receptor concentrations in menopausal women with and without depression. Int J Gynecol Obstet 79 (2002) 51-52
10. Yasui T., Maegawa M., Tomita J., et al. Association of serum cytokine concentrations with psychological symptoms in midlife women. J Reprod Immunol 75 (2007) 56-62
11. Sluzewska A., Rybakowski J.K., Laciak M., Mackiewicz A., Sobieska M., and Wiktorowicz K. Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann NY Acad Sci 762 (1995) 474-476
12. Tuglu C., Kara S.H., Caliyurt O., Vardar E., and Abay E. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacol (Berl) 170 (2003) 429-433
13. Prabhakar U., Eirikis E., Reddy M., et al. Validation and comparative analysis of a multiplexed assay for the simultaneous quantitative measurement of Th1/Th2 cytokines in human serum and human peripheral blood mononuclear cell culture supernatants. J Immunol Meth 291 (2004) 27-38
14. Yasui T., Maegawa M., Tomita J., et al. Changes in serum cytokine concentrations during the menopausal transition. Maturitas 56 (2007) 396-403
15. Ligthart G.J., Corberand J.X., Fournier C., et al. Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech Ageing Dev 28 (1984) 47-55
16. Greene J.G. Constructing a standard climacteric scale. Maturitas 29 (1998) 25-31
17. Basterzi A.D., Aydemir C.A., Kisa C., et al. IL-6 levels decrease with SSRI treatment in patients with major depression. Hum Psychopharmacol Clin Exp 20 (2005) 473-476
18. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance for industry: estrogen and estrogen/progestin drug products to treat vasomotor symptoms and vulvar and vaginal atrophy symptoms-recommendations for clinical evaluation. Rockville, MD: Division of Drug Information, Center for Drug Evaluation and Research; 2003.
19. Lanquillon S., Krieg J.C., Bening-Abu-Shach U., and Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22 (2000) 370-379
20. O'Brien S.M., Scully P., Fitzgerald P., Scott L.V., and Dinan T.G. Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J Psychiatr Res 41 (2007) 326-331
21. Besedovsky H.O., and del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev 17 (1996) 64-102
22. Judd A.M., Call G.B., Barney M., et al. Possible function of IL-6 and TNF as intraadrenal factors in the regulation of adrenal steroid secretion. Ann NY Acad Sci 917 (2000) 628-637
23. Musselman D.L., Miller A.H., Porter M.R., et al. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry 158 (2001) 1252-1257
24. Yasui T., Uemura H., Tomita J., et al. Association of interleukin-8 with hot flashes in pre-, peri- and postmenopausal women and bilateral oophorectomized women. J Clin Endocronol Metab 91 (2006) 4805-4808
25. Noguchi M., Yuzurihara M., Kase Y., Yasui T., and Irahara M. Involvement of cytokine-induced neutrophil chemoattractant in hypothalamic thermoregulation of luteinizing hormone-releasing hormone. Endocrinology 149 (2008) 2899-2906
26. Stearns V., Beebe K.L., Iyengar M., and Dube E. Paroxetine controlled release in the treatment of menopausal hot flashes. JAMA 289 (2003) 2827-2834
27. Maes M., Song C., Lin A., et al. Negative immunoregulatory effects of antidepressants: inhibition of interferon-γ and stimulation of interleukin-10 secretion. Neuropsychopharmacology 20 (1999) 370-379
28. Kubera M., Lin A.H., Kenis G., Bosmans E., van Bockstaele D., and Maes M. Anti-inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio. J Clin Psychopharmacol 21 (2001) 199-206
29. Koldzic-Zivanovic N., Tu H., Juelich T.L., et al. Regulation of adrenal glucocorticoid synthesis by interleukin-10: a preponderance of IL-10 receptor in the adrenal zona fasciculata. Brain Behav Immun 20 (2006) 460-468
30. Krishnaswamy G., Kelley J., Yerra L., Smith J.K., and Chi D.S. Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J Interferon Cytokine Res 19 (1999) 91-104
31. Yla-Herttuala S., Lipton B.A., Rosenfeld M.E., et al. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 88 (1991) 5252-5256
32. Takahashi K., Mizuarai S., Araki H., et al. Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice. J Biol Chem 278 (2003) 46654-46660
33. Leo R., Di Lorenzo G., Tesauro M., et al. Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: Pilot observations on the effects of selective serotonin reuptake inhibitor therapy. J Clin Psychiatry 67 (2006) 1760-1766
34. Denys D., Fluitman S., Kavelaars A., Heijnen C., and Westenberg H.G.M. Effects of paroxetine and venlafaxine on immune parameters in patients with obsessive compulsive disorder. Psychoneuroendocrinology 31 (2006) 355-360
35. Mizowaki M., Toriizuka K., and Hanawa T. Anxiolytic effect of Kami-Shoyo-San (TJ-24) in mice: possible mediation of neurosteroid synthesis. Life Sci 69 (2001) 2167-2177
36. Toriizuka K., Kamiki H., Ohmura N., et al. Anxiolytic effect of Gardeniae Fructus-extract containing active ingredient from Kamishoyosan (KSS), a Japanese traditional Kampo medicine. Life Sci 77 (2005) 3010-3020
37. Matsumoto K., Kohno S.-I., Ojima K., Tezuka Y., Kadota S., and Watanabe H. Effect of methylenechloride-soluble fraction of Japanese angelica root extract, ligustilide and butylidenephthalide, on pentobarbital sleep in group-housed and socially isolated mice. Life Sci 62 (1998) 2073-2082